å»è¬åå ¬è¡šãããæŽå¯
ç®èçãŸãã¯ã¢ãããŒæ§ç®èçãšãåŒã°ããæ¹¿ç¹ã¯ãçºç¹ãç®èã®èµ€ã¿ãããã³ããã¿ã®ç®èã«ãã£ãŠç¹åŸŽä»ããããŸãã æ¹¿ç¹ã«åœ±é¿ãåããç®èã®é åã¯ã人ãã人ãŸã§å€åããéºäŒåãå ç«ç³»ç°åžžæ©èœãç°å¢èŠå ãç®èã®éå£ã®æ¬ é¥ãããã³äžéšã®æŽ»åã¯ç®èãéåžžã«ææã«ãªãå¯èœæ§ããããŸãã æ¹¿ç¹ã®åŠçœ®ã¯ã¹ããã€ãã®ã¯ãªãŒã ããã³ä¿æ¹¿å€ãã»ãšãã©å«ãã§ããŸãã ããã€ãã®æ·±å»ãªã±ãŒã¹ã§ã¯ãç®èææçãæ€åºãããå Žåãæçç©è³ªãåŠæ¹ãããŸãã ãŸããåžå Žæé·ã®æšé²èŠå ãšããŠæ©èœããæ¹¿ç¹æ²»çã®ããã®åžå Žéžæãç ç©¶æ©é¢ãæ¿åºæ©é¢ã«ãã£ãŠçŸåšå€ãã®ç ç©¶éçºãè¡ãããŠããŸããäžçã®æ¹¿ç¹æ²»çåžå Ž - ã³ãããŠã€ã«ã¹ã®åœ±é¿(... ãã£ãšèŠã
å åèçŸæ£(CAD)ã¯ãè¡æ¶²ãæ é€çŽ ãé žçŽ ãå¿èã«äŸçµŠããæå·ãç æ°ã®è¡ç®¡ã®ããã«éçºãããç ç¶ã§ãã å åèã®å¿èç ã¯ãåèå ã®ã³ã¬ã¹ãããŒã«ã®ç«ç ã®å ç©ã«ãã£ãŠç¹åŸŽä»ããããŸãã ç«ç ã®å¢å ã¯ãæçµçã«å¿èãžã®è¡æµãæžå°ãããããšã«ãããå åèãçãããŸãã å¿èãžã®è¡æµã®æžå°ã¯ãå®å šãªéå¡ã®åŸã§å¿èçºäœã«ã€ãªããåŒåžãšèžã®çã¿ã®äžè¶³ãåŒãèµ·ãããŸãã å åèçŸæ£ã¯ãå«ç ãé«è¡å§ãé«ã³ã¬ã¹ãããŒã«ãç³å°¿ç ãŸãã¯ã€ã³ã·ã¥ãªã³èæ§ã座ç¡ã®ã©ã€ãã¹ã¿ã€ã«ãããã³é«è¡å§ã«ãã£ãŠåŒãèµ·ããããã å åèçŸæ£ã®çºçã«é¢äžããä»ã®èŠå ã«ã¯ãè¥æºãèº«äœæŽ»åçãé«ã¹ãã¬ã¹ãããã³äžå¥åº·ãªé£äºãå«ãŸããŸãã ... ãã£ãšèŠã
éæŽ»åèè±æ²»çåžå Žãæ²»çã¿ã€ãå¥ïŒè¬ç©çæ³ãç¥çµèª¿ç¯çæ³ããããªãã¹æ¯çŽ æ³šå°ãè¡åçæ³ïŒãçŸæ£ã¿ã€ãå¥ïŒæ¹¿æ§é掻åèè±ããã³ä¹Ÿæ§é掻åèè±ïŒããšã³ããŠãŒã¶ãŒå¥ïŒç é¢ãå°éã¯ãªããã¯ã倿¥æè¡ã»ã³ã¿ãŒãªã©ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
è³ã®åºè¡ã¯ãŸããè³ã®å·ãé è³ã®åºè¡ãšããŠç¥ãããè³ã®åºè¡ã¯ãè¡ç®¡ã®ç Žè£ãšè³ã®å é¢ãŸãã¯äžé¢ã«åºè¡ãåŒãèµ·ããçåœãè ããå¥åº·ç¶æ ãæããŸãã è³ã®åºè¡ã®åå ã®äžéšã«ã¯ãé ãã©ãŠããaneurysm(åèå£ã匱ããããšã«ããåèã®è «ã)ãé«è¡å§ãå 倩æ§è¡ç®¡ç°åžžãè³è «çãè¬ç©ä¹±çšãè¡åç ãªã©ã®åºè¡é害ãå«ãŸããŸãã ç æ°ã®çްèè²§è¡ãªã©ã è³ã®åºè¡ã¯ãçªç¶ã®é床ã®é çãåãæ°ããã¯ãã¯ãã¯ãã¯ãã¯ãã¯ãçºããå·éã®åªå€±ãååã®å»åŠçæŽå²ã®ãªãçºçãèŠèŠã®å€åãæèã®åªå€±ãçºèšã®é£ãããè¢ã®åŒ±ã¿ããã©ã³ã¹ã®åªå€±ããã®ä»ã è³åºè¡ã¯åºè¡ã®ãµã€ãã«åºã¥ããŠ3ã€ã®ã¿ã€ãã«åé¡ããããšãã§ããŸããããªãã¡ãè³... ãã£ãšèŠã
ã¢ã«ãã€ã³ãããã¬ãã«ãã§ã€ã³ããã®ä»ã®é¡äŒŒè¬ã¯ããªããªã€ãè¬ã®ã«ããŽãªã®äžã«èœã¡ãŸãã ãªããªã€ãã¯ããããŒã·ãŒãããåŸããããŸããè³ã«ååšãããªããªã€ãå容äœãšçžäºäœçšããåæ§ã®ç¹æ§ãæããåæããã³ååæååç©ããåŸãããã ããã€ãã®åŠæ¹ãªããªã€ãã¯æ€ç©ããçŽæ¥äœãããŠããŸã, ä»ã®äººã¯åãååŠæ§é ã䜿çšããŠç 究宀ã®ç§åŠè ã«ãã£ãŠäœãããŠããŸã. ãªããªã€ãã¯é®éç&é®ç广ããããçã¿ç®¡çã«äžè¬çã«äœ¿çšãããŠããŸãã ãŸããbuprenorphineãªã©ã®ãªããªã€ãã¯ããªããªã€ãäŸåçã®ç¶ææ²»çã«äœ¿çšãããŸãã ã¢ã«ãã€ã³ãããã¬ãã«ãã§ã€ã³ãããã³ãã®ä»ã®é¡äŒŒè¬ã¯ãå€å·æ§ã... ãã£ãšèŠã
Myopia ãŸã㯠closesightedness ã¯é »ç¹ã«èгå¯ãããç®ã®ç¡ç§©åºã§ããããã®äººã¯é ãé¢ããç©äœãèŠãããšãã§ããŸãããè¿ãã®ç©äœããžã§ã³ã«åœ±é¿ãäžããŸããã çŒã¬ã³ãºåœ¢ç¶ã®å€åã«ãããå ç·ã®æ²ã(åå°)ã«ã€ãªãããæ£é¢ã«ã€ã¡ãŒãžãéäžããã ã¬ãã£ã 代ããã«ãç¶²èã ãŸãããã¬ãœãã¢ã¯ãè¿ãã®ãªããžã§ã¯ãã«éäžããç®ã®ã°ã©ããŒã·ã§ã³ãã¹ãå«ãæ¡ä»¶ã§ãã èåã®éšåãšããŠèªç¶ã«èгå¯ãããŸãã Presbyopiaã¯éåžžãäžã40ç§ã§èšºæããã幎霢ã®é²è¡ã䌎ãç¶æ ãæªåããŸããå šäœçãªmyopiaåã³presbyopiaã®ç¹çŒã®äœäžã®åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$52... ãã£ãšèŠã
æå©å°¿è¬åžå Žãè¬å€ã¿ã€ãå¥ïŒãã¹ã¢ãã¬ã·ã³ãããœãã¬ã·ã³ããã«ãªãã¬ã·ã³ãªã©ïŒãæäžçµè·¯å¥ïŒçµå£ã泚å°ã錻è å ïŒãé©å¿çå¥ïŒå°¿åŽ©çãå€å°¿çïŒå€å°¿çïŒãå€éé »å°¿ãè¡åç Aããã©ã³ã»ãŽã£ã¬ãã©ã³ãç ãè¡ç®¡æ¡åŒµæ§ã·ã§ãã¯ãªã©ïŒããšã³ããŠãŒã¶ãŒå¥ (ç é¢ãå°éã¯ãªããã¯ãåšå® å»çæœèšãªã©)ãæµéãã£ãã«å¥ (ç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±)ãå°çå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«)... ãã£ãšèŠã
ã¢ã¿ãã·ã¢ã¯ãè³å ã®è¡æž ã«é¢é£ãã倿§é害ã®ã°ã«ãŒãã§ãããããã¯äœã®ãã©ã³ã¹ãšèª¿æŽãæ åœããŠããŸãã ã¢ã¿ãã·ã¢ã¯ãæ²»çãããŠããªãã ãã§ãªãã匱ããéåã®é£ãããªã©ããã®çç¶ã ããæ²»çããããšãã§ããŸãã ã¢ã¿ãã·ã¢ã¯ãã¹ãããã§ãã«ã¢ã¿ãã¢ãããªãŒããªãã®ã¢ã¿ãã¢ãã¢ã¿ãã·ã¢-telangiectasiaãè€æ°ã®ã·ã¹ãã ã¢ãããã£ãŒ(MSA)ããšããœdicã¢ã¿ãã¢ãªã©ãããã€ãã®ã¿ã€ãã§ããããšãã§ããŸãã Spinocerebellar ataxia (SCA) ã¯ãè³å ã®ç¥çµç·ç¶ã®é害ã«ã€ãªããéºäŒåã®æ¬ é¥ãåå ã§åŒãèµ·ããããåŸã£ãŠcerebellumã®çºçãåŒãèµ·ãããŸãã ãã®... ãã£ãšèŠã
Prothrombinã®è€éãªæ¿çž®ç©ã¯èŠå XIã®åãå€ãã®åŸã§å€§ããè¡ãããããŒã«ã®croprecipitateã®supernatantããã®ã€ãªã³äº€æã¯ãããã°ã©ãã£ãŒã®ããã»ã¹ã«ãã£ãŠè£œé ããã ã¢ã³ãããã³ãã³ãåãåãã ãããã®æ¿çž®ç©ã¯çŽç²ãªèŠå IXãæç€ºãããŠããªãå Žåã®hemophilia Bã®å Žåã«ã¯åºè¡ãæ±ããé²ãã®ã«äœ¿çšãããŠããŸããããããã³ãã³ã®è€éãªéäžçãªåžå Žæé·ãé転ããæ°èèŠå ã¯ãè¡åç Bã®æ®åãé«ãŸã£ãŠããŸãäŸãã°ãçŸç 察çã»ã³ã¿ãŒ(CDC)å ±åæžã«ãããšããã¢ãã£ãªã¢ 5,000人ã®çã®ç·æ§ã®åºç£ã®ãã¡1ã§èµ·ããã ããã¯ãã¢ãã£ãªã¢Bããã4å以äžäžè¬çã§... ãã£ãšèŠã
çèã®ããŒãã¯ãçèã®å¥çŽã硬ããªãããŸãã¯ã¹ããºã ãç¡æã«é¢äžããç¶æ ã§ãã ã¹ãã¬ãããæ£æ©ãç§»åã話ãé£ããçèã®å¥çŽã 䌞瞮æ§ã¯ãã¹ãã¬ããåå°ãšçèã®å¶åŸ¡ãæ åœããè³ãšèé«ã®é åãžã®æå·ã«ãã£ãŠåŒãèµ·ããããŸãã ããã¯ãçèã«éãããé»å®³ããã³åºæ¿çãªä¿¡å·ã®äžåè¡¡ã«ããããšãã§ããŸãã è³ã®å·å®³ãèé«ã®å·å®³ã倿°ã®è¶³è·¡çãè³ã®palsyããŸãã¯ææãä»ããŠãã人ã ã¯spasticityã®å¥ã®çšåºŠãæã€ããšãã§ããŸããäžçèŠæš¡ã®åžå Žãè©äŸ¡ããããšæšå®ããã US$ 4,167.6 çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠8.9% äºå ±æéäž (2021-2028... ãã£ãšèŠã
è³å èºçŸæ£(ILD)ã¯ãèºç·ç¶çãè¡ç®¡ããã³æ°éãå²ãçµç¹(èºã®ç©ºéãå²ãçµç¹)ã®ã圫å»ããæå³ããŸãã ãã®ã¹ã«ãŒãªã³ã°ã¯ãèºçµç¹ã®ç¡¬ããçããããåŒåžãå°é£ã«ããããšãã§ããŸãã ILDã¯èºã«éããããããŸãã¯ããã¯ããã£ã®ä»ã®éšåã«åœ±é¿ãäžãããããããªãæ¡ä»¶ã«é¢ä¿ããããšãã§ããŸã é¢ç¯ãªãŠãã ãŸãã¯ãµã«ã³ã€ããŒã·ã¹ã 鿥èºçŸæ£ã®ã»ãšãã©ã®äººã¯ã次ã®ãããªå°é£ãªåŒåžãããçç¶ããããŸããæ¯ã®äžè¶³ãã¬ãŒãã³ã°éåå ¬å·®ãäžããã¹ã¿ããééæå€±äŸãã°ããšãŒãããã®åŒåžåšãžã£ãŒãã«ã§2017å¹Žå ¬è¡šãããã¬ããŒãã«ãããšã1170ã®è³ç¥çµçŸæ£çäŸãå ±åãããã å šäœçãªåªå é äœã¯97.9ã§ã... ãã£ãšèŠã
è³ããã¯ãè «çãšåŒã°ããå¡ã圢æããè³å ã®çްèã®å¢æ®ã§ããã è³çµç¹å ã§ãã现è(æªæ§çްè)ãçããè³é害ã§ãã ç现èã¯çèå¶åŸ¡ãæèŠãèšæ¶ããã³ä»ã®ããã£æ©èœã®ãããªè³æ©èœãšå¹²æžããççµç¹(è «ç)ã®åºãŸããäœãåºãããã«å¢å ããŸãã è³çµç¹ããçºçãããã现èã¯ãç¬¬äžæ¬¡è³è «çãšåŒã°ããŠããŸããã身äœã®ä»ã®éšåããè³ã«åºããè «çã¯è»¢ç§»ãŸãã¯äºæ¬¡è³è «çãšåŒã°ããŸããç¬¬äžæ¬¡è³è «çã¯ãæ§ã ãªè³çµç¹(äŸãã°ãã°ã©ã€ã¢ã«ã»ã«ãã¢ã¹ãããµã€ãããã³ä»ã®è³çްèã¿ã€ã)ããéçºããããšãã§ããŸãã 転移æ§è³ããã¯ãè»¢ç§»ã®æ¡å€§ã«ãã£ãŠåŒãèµ·ããããŸã ãã现è 身äœã®èåšããè³ãŸã§ã 2021幎9æã«ã¯ãã¢ã¡... ãã£ãšèŠã
Vasopressinã¯æå©å°¿ãã«ã¢ã³ã§ãã è èãè¡ç®¡ã«äœçšããäžåäœã«ãã£ãŠèªç¶ã«åæ³ãããŸãã Vasopressinã¯ç³å°¿ç ã®insipidusã®åŠçœ®ã§ããã³å€ç§ã®åŸã§ãŸãã¯è ¹éšXç·ã®éã«èã®ç¹å®ã®æ¡ä»¶äœ¿çšãããŸãã ããã¯çèãç®ã®äžããŸãã¯éèã«ç®¡çãããŸããäžççãªããœãã¬ãã·ã³åžå Žã¯äŸ¡å€ããããšæšå®ããã 1,112.6çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠14.7%(çšæ) äºæž¬æéãè¶ ã㊠(2021-2028).ãããã£ãŒã« 1. ã°ããŒãã«Vasopressin 2021幎(æå20幎) å°åå¥äŸ¡å€ã®æšç§»èªåŸç¥çµæ©èœäœäžç(AD)ã®æ®åãã°ããŒã... ãã£ãšèŠã
錻ããªãŒãæ²»çè¬åžå Žãè¬å€ã¯ã©ã¹å¥ïŒã³ã«ãã³ã¹ããã€ããæçç©è³ªãæãã¹ã¿ãã³è¬ãã€ã³ã¿ãŒãã€ãã³é»å®³å€ãã¢ãã¯ããŒãã«æäœãªã©ïŒãæäžçµè·¯å¥ïŒçµéŒ»ãçµå£ãéçµå£ïŒãæµéãã£ãã«å¥ïŒç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
æšççæ³ã¯çã®ããã®æ°è¬ççæ³ã§ãã 粟å¯ããæ²»çã®äžçš®ã§ãã èè±ãããèè±ãããå€§è žãããçœè¡ç ãèãããèºããããªã³ãè «ããã³åç«è ºããã®æ²»çã«äœ¿çšãããæšççæ³ã æšççæ³ã¯ç¹å®ã®åºåãç©è³ªãã§èŠã€ããæ»æããããã«ãªãããŸã ãã现èãåãåããäžççãªæšççæ³ åžå Žã¯è©äŸ¡ããããšæšå®ãããŸã US$ ãã 98.6 ãã³ ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠9.0% äºå ±æéäž (2021-2028).å³1.ã°ããŒãã«ã¿ãŒã²ãã å€(US $ Billion)ãå°åå¥ã2021åžå Žéžæã«ããç ç©¶éçºã«éç¹ã眮ããã®ã¯ãäºæž¬æéã«ãããäžççãªæšççæ³åžå Žæé·ãä¿é²... ãã£ãšèŠã
åºç€çްèã®ã«ã«ãããŒã(BCC)ã¯å¶åŸ¡ãããç°åžžãªæé·ã¯äžè¡šç®ã®åºå¹¹çްèã§èŠãããŸãã ããã¯ä»ã®èº«äœéšåã«åºãããŸãããããŸããªç¶æ ã§ã¯ãããã¯è»¢ç§»ããçåœãè ãããšããŠèšŒæããããšãã§ããŸããããããããã¯ç®èãéªšã«æ·±ãè¡ããããããŸããã BCCäžã«åœ¢æããã玫å€ç·ãç å€ã®éé²ãåå ã§ããªãŒãã³ãœãŒã«ãèµ€ããããããŸãã¯æã ãã³ãã®ããã«èŠããŸãã æè¡ãè¬ããã®ä»ãå«ãããµã«çްèçã®æ²»çã«äœ¿çšã§ããããŸããŸãªæ²»çãªãã·ã§ã³ããããŸããã°ããŒãã«ããµã«ã»ã«ã«ã«ãããŒãåžå Žã¯ã US$ 6,721.4 çŸäžå ãåãåãã 2021幎 å±ç€ºäºå® ã«ã°ã¬ ã«ã€ã㊠7.9% äºå ±æéäž (2... ãã£ãšèŠã
Beta thalassemiaã¯ãæ£è ã®äœããã¢ã°ããã³ãæ®éã«äœããªãçžç¶ãããè¡ã®ç¡ç§©åºã§ãã ãã¢ã°ããã³ã¯ã人äœå šäœã«é žçŽ ãéã¶èµ€è¡ç(RBC)ã®äžéšã§ãã ç°åžžãã¢ã°ããã³ã¯è²§è¡(äœå ã®ååãªRBCã§ã¯ãªã)ããã³ä»ã®å»åŠçåé¡ã®åŒ±ããæ¯ã®äžè¶³ã«ã€ãªããããšãã§ããŸãã ããŒã¿è¡ç³ã®çš®é¡ã«å¿ããŠãçç¶ã¯è»œåºŠãŸãã¯éåžžã«é床ã§ãã ããã«ãèšåºçã«ã¯ãè¡æ¶²èŒžè¡äŸåæ§è¡ç³(TDT)ããã³é茞è¡äŸåæ§è¡ç³(NTDT)ã®æ£è ã®å¿ èŠæ§ã«åºã¥ããŠããŒã¿è¡çã®æ£è ã®2ã€ã®äž»èŠãªã«ããŽãªããããŸãã ããŒã¿ thalassemia ã®èšºæã¯ 12 ãæã®å¹Žéœ¢ã®åŸã®ãã€ã¯ãå¢èæ§äœè¡çãæ žã«ãããèµ€... ãã£ãšèŠã
ççåŠçãªããããã¯ç°ãªã£ã容åšã«æ¶²äœãæ··åãããããŸãã¯ç§»ãå®éšå®€ã§äœ¿çšãããŸãã ãããã®ããããã¯ãæ¶²äœ(ããªãªããã«ãŸãã¯ml)ãæž¬å®ããã®ã«åœ¹ç«ã€åŽé¢ã®ã°ã©ããŒã·ã§ã³ãä»å±ããŠããŸãã æãäœãå¢åã¬ãã«ã枬å®ãã粟床ã®ããã«ãã»ãããžã«ã«ããããã¯äœ¿çšã®ããã«æãæšå¥šãããŸãã ããããã®ã°ã©ããŒã·ã§ã³ããŒã¯ã¯ããããã®ããããã®å 端ã«è¿ãã§ãã 空æ°ãéåå§åã䜿çšããŠãå 端ã«ä»ããŽã è£œçæ ¹ã¯äœåãªè§£æ±ºãå¹ãã®ã«äœ¿çšãããŠããŸãã å¹ãåºãã®ããããã¯éåžž2ã€ã®ãªã³ã°ãšåé¡ãããŸãã åãæ±ã人ã¯ã空æ°å§ãæäŸããä»å±ã®é»çã䜿çšããŠãæ¶²äœã®ãã¹ãŠã®æåŸã®æ»Žããã©ã¹ãã¢ãŠãããå... ãã£ãšèŠã